The role of PTP1B in negatively regulating the insulin and leptin signalling pathways and the downstream effects on glucose homeostasis and body mass, which result in metabolic disorders such as type 2 diabetes and obesity, are well established [80,81]. Here, PTPN1 is linked to obesity disorder.